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Abstract
Background: N-ethyl-N-nitrosourea (ENU) mutagen has become the method of choice for inducing random
mutations for forward genetics applications. However, distinguishing induced mutations from sequencing errors or
sporadic mutations is difficult, which has hampered surveys of potential biases in the methodology in the past.
Addressing this issue, we created a large cohort of mice with biological replicates enabling the confident calling of
induced mutations, which in turn allowed us to conduct a comprehensive analysis of potential biases in mutation
properties and genomic location.
Results: In the exome sequencing data we observe the known preference of ENU to cause A : T ⇒ G : C transitions
in longer genes. Mutations were frequently clustered and inherited in blocks hampering attempts to pinpoint
individual causative mutations by genome analysis only. Furthermore, ENU mutations were biased towards areas in
the genome that are accessible in testis, potentially limiting the scope of forward genetic approaches to only 1–10 %
of the genome.
Conclusion: ENU provides a powerful tool for exploring the genome-phenome relationship, however forward
genetic applications that require the mutation to be passed on through the germ line may be limited to explore only
genes that are accessible in testis.
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Background
Chemically-induced mutations in the model organisms
and screening the resulting phenotype has proven to be a
powerful tool for annotating gene function and to uncover
the biological mechanisms of diseases [1, 2].
Malaria remains the third lethal disease and affect
mostly children and non-immune adults [3]. The rapid
spread of drug-resistant malaria parasites remains a deep
concern [4]. A novel strategy is urgently needed to com-
bat the rapid development of drug-resistant parasites.
Genetic diseases affecting the red blood cell are com-
mon in populations resident in malarial endemic regions
[5]. Genetic mutations in HbS, HbC, HbE and G6PD or
both and β-thalassaemia are protectives as heterozygotes
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against malaria [6]. These genetic mutations that are pro-
tective against malaria could be described as endogenous
antimalarial therapies and the parasite has difficulty in
developing resistance against the host [7]. The aim of
this project was to uncover novel host-encoded targets by
producing lines of mice that survive an otherwise lethal
P. chabaudi infection, but also to screen for abnormal
red blood cells count as most human mutations giving
rise to resistance have an abnormal red cell phenotype
in either the homozygous and/or heterozygous state [6].
N-ethyl-N-nitrosourea (ENU) is themutagen of choice for
inducing random mutations into the mouse or zebrafish
genomes (see [8, 9]).
ENU causes alkylation of nucleotides with subsequent
mispairing and ultimately base-changes after replication.
Justice et al. [10] reported that the most common muta-
tions induced by ENU in the mouse genome are A:T
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to T:A transversions at the DNA level, and at the pro-
tein level are inducing mainly missense mutations, but
also non-sense mutations, as well as alternative spicing
mutations, gain-of-stop mutations, intronic mutations or
noncoding mutations causes amino-acid changes, folding
or expression of the protein [2].
ENU was used to induce new mutations in a strain of
mouse that is normally susceptible to the rodent malaria
parasites. The mice were challenged with P. chabaudi or
P.berghei parasites and selected, as animals of interest,
those that survived to the infection or displayed an abnor-
mal red blood cell count. As is the case with the natural
mutants found in endemic malaria infection areas, these
induced mutations resulted in mice surviving a malar-
ial infection and marked possible novel host targets. This
property can be used to randomly introduce single base-
pair mutations, thereby surveilling the genome’s function
and potential in an unbiased fashion.
However, a recent study sequencing Toxoplasma gondii
genomes after ENU mutageneis revealed that the intro-
duced changes were not randomly distributed in the
genome [11]. While they confirmed Justice et al. [10]
observation of ENU’s proclivity for inducing mutations
at A/T base pairs (78.6 %), they also observed a higher
transition (ti) compared to transversion (tv) rate (ti/tv
ratio 1.20) [11]. Similar biases may be present in ENU-
based phenotype screens in mice, as indicated by Barbaric
et al. [8], who did a meta-analysis of all reported ENU
mutations from targeted gene studies. They observed
that ENU targeted genes had higher coding sequence
length, higher exon number and had a higher GC con-
tent than the average for themouse genome. Furthermore,
ENU mutations were often directly flanked by G or C
nucleotides.
Here we investigate the observations made by Barbaric
et al. on a sequencing cohort of ENU treated mice. Specif-
ically, we discuss how to distinguish ENU-induced vari-
ants from lab-strain specific, germline single nucleotide
polymorphisms (SNPs) and sporadic somatic variants.
Furthermore, we investigate biases in the ENU variant
distribution due to DNA sequence motifs or open chro-
matin structure in the targeted tissue.
Results and discussion
Coverage and ENU statistics
We received on average 74 million reads (ste = 2531660)
from exome sequencing of which on average 94.8 %
(ste = 0.2) mapped to the genome with 90.4 % (ste = 0.3)
being paired using BWA and 97.9 % (ste = 0.2) map-
ping with 93.2 % (ste = 0.2) being paired using BOWTIE2.
The mean coverage over the captured exons was 53.3 %
(ste = 20.5) and 56.2 % (ste = 21.6), respectively, with on
average 75.0 % (ste = 11) and 77.4 % (ste = 10.5) of bases
being covered with 25× (see Additional file 1: Table S1).
Table 1 shows that on average 13,775,275 variants are
called by the various variant calling methods for all mice.
We removed the likely false positives by filtering out
discordant variants (not present in all offspring from a
founder) and non exclusive variants (variants also present
in other founders) to only on average between 39 and
66 variants per method (P1-P4) and for each mouse.
The rational for this is that the ENU variants are by
probability unlikely to be identical in other independent
founders line.
For the next filtering step, we took the union over the
four methods resulting in an average of 111 variants per
mouse. We aimed to reduce the false positive rate further
by requiring two or more methods to support the vari-
ant call, which reduces the set to 79 variants per mouse.
We further reduced the set by removing variants that are
not consistent with the genetics of the phenotype segrega-
tion resulting in an average of 56 variants per mouse. The
ENU candidate variants were further refined by filtering
out variants that did not pass the GATK quality con-
trol, which assesses alignment statistics (e.g. read depth),
resulting in 21 variants on average per mouse and 1281
variants in total over all 53 founders. This very stringent
filtering regime was designed to reduce the false positive
rate with already 39 identified variants confirmed as ENU
mutations (data not shown).
Mice with a SJL background had 60 % more pre-
dicted ENU mutations than C57BL/6 (t-test p-value =
0.01575), which makes the background the determining
factor for ENU mutation number over sequencing depth,
sequencing provider or capture technology (Additional
file 1: Figures S1–S4) potentially resulting from a elevated
Table 1 The table shows the variant numbers identified by the
different methods through the different filtering steps. Note,
mean raw calls per mouse is not available for P4 as GATK calls
jointly over all mice. Pass QC involves filtering for olfactory genes,
known Sanger variants and PASS flag from GATK
P1 P2 P3 P4
Mean raw calls 13,775,275
Mean raw calls 66,493 71,705 74,093 NA
per mouse
Total raw calls 145,484 131,926 124,788 54,698,903
(for 53 founders)
Mean filtered 39 44 41 66
SNVs per mouse
Mean combined 111
filtered SNVs
Mean agreeing 54
SNVs
Mean pass QC 21
Total ENUmutation 1281
(for 53 founders)
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dose of ENU injection for SJL mice. Locations with
ENU mutation had lower coverage than the average in
the genome (52 vs 57). This was statistically significant
(log-transformed t-test p-value = 2.2 · 10−16) reduction
but can be explained with them predominantly being
located in exonic regions (see Fig. 1), which tend to have
less sequence duplications or repetitive regions and as a
result have consistent coverage. The correlation coeffi-
cient between overall coverage and ENU mutation cover-
age was 0.39 and p-value = 2.2 · 1016 (Additional file 1:
Figure S5). 40 % to 60 % of the putative ENU variants were
nonsynonymous and on average less than 20 % were syn-
onymous with the rest were unknown as they were located
intronic or in the 3’UTR (see Fig. 1).
ENU induced variants have different profiles than germline
and somatic variants
ENUmutations are enriched in longer genes
As reported by Barbaric et al. [8], genes targeted by
ENU tend to have a higher coding sequence length than
the average mouse gene. We also observe this reported
bias in our dataset with genes containing one or more
ENU mutations having an average of 88,499 bp compared
to the average gene length of 26,550 bp in the mouse
genome (log-transformed t-test p-value = 2.2 · 10−16).
This can be explained by the simple fact that the longer
a gene the higher its probability of incurring a muta-
tion. However contrary to the results by Barbaric et al.,
the GC content in our dataset is significantly lower than
the mouse genome average (45.6 % vs 46.1 % p-value =
0.006). To avoid selection bias, we investigated the G1
generation only as no phenotype selection was performed
at this stage of breeding (653 variants in 21 founders).
However, the results for G1 mirrored the full dataset
(see Table 2). We also compared two publicly available
datasets of reported ENU mutations. Here we also found
a significantly increased gene length for ENU mutations
in Mutagenetix (p-value = 2.2 · 10−16) and Phenomics
(p-value = 2.2 · 10−16), respectively, while the GC content
was found not to be significantly different from the mouse
average (see Table 2).
ENUmutations are dominated by A : T ⇒ G : C transitions
Next we investigated the base pair substitution rate in our
data set. As shown in Fig. 2, 20 % of the mutations were
A ⇒ G transitions closely followed by T ⇒ C transi-
tions and 15 % are A ⇒ T and T ⇒ A transversions.
We observed a similar distribution (correlation coefficient
cc = 0.986, p-value = 6.1 · 10−10) for the G1 dataset (see
Additional file 1: Figures S6 and S7) as well as the Muta-
genetix (cc = 0.993, p-value = 1.3 · 10−10) and Phenomics
(cc = 0.992, p-value = 2.8 · 10−10) datasets.
ENUmutations have no flankingmotifs
Barbaric et al. [8] reported a significant overrepresenta-
tion of G or C at either side of the mutation. To investigate
this, we extracted the flanking 10 bp sequences from the
reference genome and visualised this potential ENUmotif
using WEBLOGO [12]. As expected we found an overrep-
resentation of A and T bases, as they make up around
70 % of the targeted bases (Fig. 2), resulting in an over-
all information content of less than 0.5 at the central
position. We did not observe any other overrepresented
base in the 10 bp flanking the ENU mutation. We then
stratified by targeted base to investigate if there was a
targeted base specific motif. Due to the lower number
of involved sequences we saw certain overrepresented
bases however, they are also present in randomly selected
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Fig. 1 Functional annotation of ENU mutation per background
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Table 2 Mean of GC and gene length Note, not all identified
variants are located in annotated genes
Number of genes CG Gene length
Mouse genome 43629 46.1602 26550.38
ENU all 1186 45.6114 88498.69
ENU G1 613 45.1885 94356.03
Mutagenetix 19491 46.1220 49908.29
Phenomics 20496 46.1544 48533.53
regions (Additional file 1: Figure S8). Again, removing bias
from phenotype selection we focussed on the G1 mice
only but did not observe a motif here either (Additional
file 1: Figure S9). Finally, to remove residual bias from the
mouse strain, we focused on mice with SJL (39 founders)
and (C3H/HexSJL)F1 (four founders) background as we
had a strain specific reference genomes for these stains
before ENU mutations were introduced. The logos gen-
erated from the 1116 mutations in SJL mice represent
the logo obtained over all and investigating the 27 muta-
tions for (C3H/HexSJL)F1 did not produce a reliable motif
due to the small numbers investigated. Overall, we did
not observe a flanking motif for ENU mutations in our
dataset.
ENUmutation distribution
We plotted the ENUmutation locations along the genome
to determine whether they are uniformly distributed
or if there are factors other than gene length biasing
the distribution. Figure 3 visualises all ENU mutations
colour coded by the founder they occur in. Overall
ENU mutations were not uniformly distributed. This
becomes even more apparent when plotting the muta-
tions reported in the larger Mutagenetix and Phenomics
datasets (Additional file 1: Figures S13 and S14), where
there are areas of depletion.
One explanation for this could be that due to the subse-
quent phenotype screening it is likely that ENUmutations
are located in protein coding genes, which in turn are
non-uniformly distributed in the genome. To test this, we
count how many genes have at least one ENU mutation
when randomly shuffling ENU locations (1000 times). We
observe on average 24.71 genes to be targeted by the real
ENU mutations per mouse compared to 10.95 when ran-
domly selecting locations, under the Poisson distribution
seeing this many genes given the lambda of 11.13 is highly
unlikely (0.0002), which is not surprising give the sequenc-
ing assay. However, when restricting the shuffling to gene
locations only we observe on average 25.45 genes, though
not statistically significant (Poisson 0.44), ENU mutations
seem to be more clustered thereby targeting less genes.
A density plot (Additional file 1: Figure S16) of targeted
genes for ENU mutations versus random locations in the
exome shows that the underlying distributions could be
different specifically in the tail. We therefore hypothesise
that ENU mutations are not independent and there are
additional limiting factors other than gene location.
ENUmutation are inherited in blocks
Putative ENU mutations appeared to be clustered by
founder (see Additional file 1: Figure S15 for an image
per founder). The average distance between ENU muta-
tions in a founder is 44 million bp (std = 38 million
bp). To determine the significance of these observa-
tions in our dataset, we calculated an empirical p-value
by shuffling the founder label for every ENU mutation
10,000 times and recalculated the distance thereby testing
p-values down to 0.0001. The resulting p-value was 0.0003
with average distance 48 million bp (std = 37 million bp).
This suggests that ENUmutations are inherited as blocks.
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Fig. 3 ENU variants cluster within each mouse. Variants are coloured by founder to display clear blocks of inheritance within mice
ENUmutation distributions biased towards open
chromatin areas
ENU mutations occur systemically, however, only the
mutations introduced in the germline are passed on to the
next generation. A hypothesis is hence that ENU muta-
tions are biased towards the parts of the genome that are
accessible in the testis, which would limit the functional
assessments to testis-specific genes.
To test this hypothesis we investigated whether ENU
mutations were enriched in open chromatin areas of testis
as determined by DNase hypersensitivity sequencing data
(DNase-Seq) and compared this against the DNase-Seq
regions of other tissues as well as randomly sampled
regions of the same size. As shown in Fig. 4, we observed a
significant enrichment of ENUmutations in testis DNase-
Seq regions compared to brain (two-sided Wilcox rank
sum test with fdr correction p-value = 0.0052), fibroblast
(0.0224), heart (0.0487), kidney (0.0358), liver (0.0056). As
there are more base pairs accessible in testis (38,505,954
bp in over 81,467 regions) compared to other tissue (aver-
age 29,442,913 bp and 68,266 regions), ENU variants have
a higher probability to fall into these regions by chance. To
investigate this, we randomly sampled 1000 times regions
of the same size and chromosome distribution as the testis
dataset and compared these values to the observed over-
lap in testis. As shown in Fig. 4, the overlap with the open
chromatin areas in testis were significantly different to
that of the randomly generated dataset (<2 · 10−16) sub-
stantiating the bias of ENU mutation towards accessible
areas. To demonstrate that this was not due to proper-
ties of the testis open chromatin region we also tested
the observed overlap to the randomly sampled genomic
regions for all other tissues and observed consistently
a significantly lower overlap in the randomly sampled
regions datasets (<2 · 10−16).
As an orthogonal test, we used histone marks to deter-
mine the open chromatin areas. As reported by Shlyueva
et al. [13], histone marks H3K4me1 and H3K27ac encode
active promoters or enhancers, while H3K27me3 flags
inactive areas. From this information we determined the
open chromatin areas (see “Methods”), and again com-
pared testis against other tissues as well as randomly
sampled testis-like regions. As shown in Fig. 4, we again
found a significant enrichment of ENUmutations in testis
DNase-Seq regions compared to heart (0.00279), kidney(
4.1 · 10−6), liver (0.01799) and random sampled regions(
3.4 · 10−12). Finally, we saw a significant depletion of
ENU mutations in areas marked by H3K27me3 to be
inactive in testis tissues compared to open chromatin
testis
(
3.1 · 10−8) or random sampling of testis regions
(0.03476).
Conclusions
ENU treatment is most effective in the accessible areas
of the genome. Phenotype screens, which require the
ENU mutation to be passed on through the germ line are
hence limited to areas accessible in testis. This limits the
explorable area to only 1–10 % of the genome depending
on which proxy for openness is used (3.3 · 108 bp His-
tone marks and 3.9 · 107 bp DNase of the 2.8 · 109 bp). We
provided a list of genes potentially not targeted by ENU
mutation (Additional file 2). Indeed when comparing to
the Mutagenetix and Phenomics dataset only between 5–
6 % of all mouse genes are repeatedly (twice) targeted by
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Fig. 4 Variants are enriched in open chromatin areas of testis. left: Percentage of ENU variants overlapping DNase hypersensitivity areas in testis and
other tissues as well as random genomic regions. right: Percentage overlap with open chromatin area as flagged by Histone modification marks
from ChipSeq experiments
ENU mutations and the overlap with closed chromatin
areas in testis is very low (jaccard statistic 8.6 · 10−5 and
0.0001, respectively).
Methods
ENU treatment
A dominant large scale ENU mutagenesis screen was
performed. SJL/J and C57BL/6 and BKS.Cg-Dock7m +/+
Leprdb/J male mice (LEPR) received by intraperitoneal
of two doses of 150 mg/kg for SJL/J mice and 100
mg/kg for the other strains of ENU (Sigma-Aldrigh, St
Louis, MO) a week apart. After 8 weeks of infertil-
ity, ENU injected mice (G0) were bred with their iso-
genic background females to generate G1 offspring. The
G1 mice were screened for various phenotypes (abnor-
mal blood count, proteinuria or resistance to rodent
malaria infection). Phenodeviant G1 mice were crossed
with C3H/He or C57BL/6 mice and progeny tested for
their heritability. All mice in this study were housed
under controlled temperature (21 °C) with a 12:12 hr
light-dark cycle. All procedures were conducted in accor-
dance with the policies of the Macquarie University
and conformed to the National Health and Medical
Research Council (NHMRC) Australian code of Practice.
The work was performed under the agreement Ethics
ARA 2012/019 and ARA 2014/55 approved and obtained
from the Animal Ethics Committees at the Australian
National University and Macquarie University.
Sequencing
DNA was collected from tails and extracted using a Qia-
gen DNAse Easy blood and Tissue Kit (Hilden, Germany)
according to the manufacturer’s instructions. Ten micro-
grams of DNA was prepared for paired-end genomic
libraries using a paired-end preparation kit from Illumina
(San Diego, Ca), following the manufacturer’s instruc-
tions. Exome enrichment was performed using an Agi-
lent Sure Select or Nimblegen mouse Exome kit accord-
ing to the manufacturer’s protocol. Enriched libraries
were tested for enrichment using quantitative PCR. The
samples were then sequenced on an Illumina Hiseq
2000 platform, which generated paired-end reads of 100
nucleotides. The libraries were multiplexed and barcoded.
The exome coverage was 50× on target.
Variant calling
Calling mutations from raw sequencing data (fastq) is
done by combining the result from four separate map-
ping and variant calling pipelines (see Additional file 1:
Figure S17) to avoid loosing variants due to algorithm
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bias. All pipelines are executed in the NGSANE [14]
framework for reproducible analysis on high performance
compute infrastructure. Note, where not stated other-
wise, the default settings were used. P1 and P2 uses
BWA V0.6.1 [15] and BOWTIE2 [16] V2.1.0 in con-
junction with SAMTOOLS [17] V0.1.19 to call variants
(mpileup -q1 -D) in each offspring-groups individually
after removal of duplicates (rmdup) and subsequent filter-
ing (vcfutils.pl-D1000 -w0 -e0). P3 and P4 also map
with BWA but in addition use GATK [18] 2.5 to realign
reads (-T RealignerTargetCreator, -T IndelRealigner) and
recalibrate the quality score (-T BaseRecalibrator, -T
PrintReads) to improve the read location and base-
pair call-accuracy. While P3 again uses SAMTOOLS, P4
uses GATK’s UnifiedGenotyper (-stand_call_conf 30.0 -
stand_emit_conf 10.0 -dcov 1000) with subsequent hard
filtering of variants (-T VariantFiltration, for mutations: –
filterExpression “MQ0 ≥ 4 && ((MQ0 / (1.0 *
(DP+1))) > 0.1)” and for mutations and indels: –mask
[called indels] –clusterWindowSize 10 –filterExpression
"QUAL < 30.0 || QD < 5.0 || HRun > 5 || SB > -0.10") to
call variants over all mouse genomes in the study simulta-
neously. In all cases, reads were mapped against Genome
Reference Consortium Mouse Build 38 (GRCm38, equiv-
alent to UCSC mm10). The known mouse variants used
during realignment, recalibration and GATK variant call-
ing were downloaded from UCSC (dbSNPv128, mm9)
and lifted-over to mm10. Only variants in the targeted
regions as provided by Agilent (lifted over from mm9)
were considered.
ENU variant filtering
We group the offspring genomes by founder and compare
the identified mutations to those from other founder-
groups. Only investigating mutations that occur in all
offspring from one founder (concordant) and not in those
from other founders (exclusive) will robustly separate seg-
regating ENU-triggered mutations from strain-specific
variants or sequencing errors. After variants are avail-
able from P1-P4 we combined the information from
all founder-groups using GATK (-TCombineVariants)
and annotated them using GATK (-TVariantAnnotator)
with dbSNPv128 and variants from Sanger’s The Mouse
Genomes Project (lifted over from mm9). We then
retained only complete and exclusive variants that have
not been annotated previously (dbSNP, Sanger) using in-
house python scripts. These scripts also filtered out vari-
ants that were only supported by one method (P1-P4) as
well as specific genotypes (homo- or heterozygous muta-
tion) that could be ruled out based on prior genetic infor-
mation. The resulting high-confidence variants were then
functionally annotated using ANNOVAR [19] (Ensembl,
MGI, dbSNP137, phastConsElements60way) and variants
overlapping olfactory genes were removed.
Open chromatin information
DNase-Seq library was downloaded fromGEO (GSE53076,
bed-files) for Pre-Sertoli cells from the testes of E15.5
mouse embryos (Sox9 Heterozygous male embryos
conceived from transgenic homozygous Sox9-ECFP
C57BL/6J male mice mated to female CD-1 (Charles
River) females) as well as heart, brain, liver, kidney and
fibroblasts. Chip-Seq data for testes, heart, liver, kid-
ney for histone marks H3K27ac, H3K27me1, H3K4me1
was downloaded from Encode ExperimentMatrix (broad-
peak). The areas of active regions are generated by
concatenating the genomic regions from H3K4me1 and
H3K27ac and removing the areas containing Chip-Seq
peaks from H3K27me1 using BEDTOOLS [20].
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approaches.MGI names and location of genes overlapping H3K27me3
histone marks, which are considered closed genomic areas and hence
potentially not targeted by ENU mutations that need to be passed on
through the germ line. (TXT 379 kb)
Abbreviations
DNase-Seq: DNase hypersensitivity sequencing data; ENU:
N-ethyl-N-nitrosourea; LEPR: BKS.Cg-Dock7m +/+ Leprdb/J male mice;
SNP: single nucleotide polymorphisms; ti: transition; tv: transversion;
UTR: untranslated region.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Conceived and designed the experiments: DCB, GB, BJM, SF. Performed the
experiments: DCB, GB. Analysed the data: DCB, GB. Contributed
reagents/materials/analysis tools: DCB, GB. Wrote the paper: DCB, GB. All
authors read and approved the final manuscript.
Acknowledgements
This work was supported by the National Health and Medical Research Council
(grant APP 605524, 490037 and 1047082), the Australian Research Council
(grant 12010061), the National Collaborative Research Infrastructure Strategy
of Australia, and the Education investment fund from the Department of
Innovation, Industry, Science and Research.
Author details
1Digital Productivity, CSIRO, 11 Julius Av, 2113 Sydney, Australia. 2Australian
School of Advanced Medicine, Macquarie University, 2 technology place, 2109
Sydney, Australia. 3John Curtin School of Medical Research, The Australian
National University, GPO Box 334, 2600 Canberra, Australia.
Received: 15 May 2015 Accepted: 13 October 2015
References
1. Greth A, Lampkin S, Mayura-Guru P, Rodda F, Drysdale K, Roberts-
Thomson M, et al. A novel enu-mutation in ankyrin-1 disrupts malaria
parasite maturation in red blood cells of mice. PloS ONE. 2012;7(6):38999.
Bauer et al. BMC Genomics  (2015) 16:866 Page 8 of 8
2. Acevedo-Arozena A, Wells S, Potter P, Kelly M, Cox RD, Brown SDM. Enu
mutagenesis, a way forward to understand gene function. Annu Rev
Genomics Hum Genet. 2008;9:49–69.
3. WHO. World Malaria Report. 2014. http://www.who.int/malaria/
publications/world_malaria_report_2014/en/.
4. Greenwood B. Treatment of malaria - a continuing challenge. N Engl J
Med. 2014;371(5):474–5.
5. Lelliott PM, McMorran BJ, Foote SJ, Burgio G. The influence of host
genetics on erythrocytes and malaria infection: is there therapeutic
potential Malar. J. 2015;14(1). doi:10.1038/sj.tpj.6500241.
6. Mangano VD, Modiano D. An evolutionary perspective of how infection
drives human genome diversity: the case of malaria. Current Opinion in
Immunology. 2014;30:39–47.
7. Foote SJ. Can nature’s defence against malaria be mimicked by the
development of host-directed therapies? Pharmacogenomics J. 2004;4(3):
141–2.
8. Barbaric I, Wells S, Russ A, Dear TN. Spectrum of enu-induced mutations
in phenotype-driven and gene-driven screens in the mouse. Environ Mol
Mutagen. 2007;48(2):124–42.
9. Kettleborough RNW, Busch-Nentwich EM, Harvey SA, Dooley CM, de
Bruijn E, van Eeden F, et al. A systematic genome-wide analysis of
zebrafish protein-coding gene function. Nature. 2013;496(7446):494–7.
10. Justice MJ, Noveroske JK, Weber JS, Zheng B, Bradley A. Mouse enu
mutagenesis. Hum Mol Genet. 1999;8(10):1955–63.
11. Farrell A, Coleman BI, Benenati B, Brown KM, Blader IJ, Marth GT, et al.
Whole genome profiling of spontaneous and chemically induced
mutations in toxoplasma gondii. BMC Genomics. 2014;15:354.
doi:10.1186/1471-2164-15-354.
12. Crooks GE, Hon G, Chandonia JM, Brenner SE. Weblogo: a sequence
logo generator. Genome Res. 2004;14(6):1188–90.
13. Shlyueva D, Stampfel G, Stark A. Transcriptional enhancers: from
properties to genome-wide predictions. Nat Rev Genet. 2014;15(4):
272–86.
14. Buske FA, French HJ, Smith MA, Clark SJ, Bauer DC. Ngsane: a
lightweight production informatics framework for high-throughput data
analysis. Bioinforma. 2014;30(10):1471–72.
15. Li H, Durbin R. Fast and accurate short read alignment with
burrows-wheeler transform. Bioinforma. 2009;25(14):1754–60.
16. Langmead B, Salzberg SL. Fast gapped-read alignment with bowtie 2.
Nat Methods. 2012;9(4):357–9.
17. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The
sequence alignment/map format and samtools. Bioinforma. 2009;25(16):
2078–079.
18. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A,
et al. The genome analysis toolkit: a mapreduce framework for analyzing
next-generation dna sequencing data. Genome Res. 2010;20(9):1297–303.
19. Wang K, Li M, Hakonarson H. Annovar: functional annotation of genetic
variants from high-throughput sequencing data. Nucleic Acids Res.
2010;38(16):164.
20. Quinlan AR. Bedtools: The swiss-army tool for genome feature analysis.
Curr Protoc Bioinforma. 2014;47:11–121111234.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
